NCT07005297View on ClinicalTrials.gov

Clinical Genetics Branch Eligibility Screening Survey

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

January 1, 2035

Study Completion Date

January 1, 2036

Conditions

MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies

Trial Locations (1)

20850

National Cancer Institute, Rockville

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT07005297 - Clinical Genetics Branch Eligibility Screening Survey | Biotech Hunter | Biotech Hunter